Radioisotopes Program

Welcome to the 3rd International Symposium on Radionuclide Therapy and Radiopharmaceutical Dosimetry

Toronto Graphic

Announcements

Second Announcement

First Announcement PDF Icon

All announcements and mailings for the Symposium will be electronic and by website postings. Those who wish to participate in the Symposium must register with SNM to attend the 2009 annual meeting. Separate registration will not be offered.

Abstract Submission Website
Submission begins November 6, 2008.
Submission ends January 13, 2009.

Registration, housing, local arrangements, transportation, and other logistical arrangements will be handled by SNM. Local arrangement details will be available on the SNM website.

Location

Metro Toronto Convention Centre. Hotel selection via the SNM registration website.

We look forward to seeing you in Toronto in 2009!

June 13 - 17, 2009 Toronto, Canada

The 3rd International Symposium on Radionuclide Therapy and Radiopharmaceutical Dosimetry and Workshop on Alpha-emitting Radionuclides in Therapy will convene June 13-17, 2009, in Toronto, Canada, in conjunction with the 2009 SNM Annual Meeting.

The 3rd Symposium has been organized by the SNM Medical Internal Radionuclide Dose (MIRD) Committee on Medical Internal Radiation Dose (MIRD), together with representatives of the Dosimetry and Therapy committees of the European Association of Nuclear Medicine (EANM), and the European Commission, Joint Research Centre, Institute for Transuranium Elements, in Karlsruhe, Germany.

Objectives

The International Symposia on Radionuclide Therapy and Radiopharmaceutical Dosimetry (ISRTRD) are designed to bring together disciplines concerned with radiopharmaceutical dosimetry and radionuclide therapy, with the objective of stimulating interdisciplinary scientific discussions.

The 3rd Symposium will blend with SNM sessions in oncology, radiopharmaceutical chemistry, radiobiology, and dosimetry. The workshop will highlight current progress in use of alpha-emitters for cancer therapy, continuing a series of successful alpha-emitter workshops.

Symposium topics for abstract submissions include:

  • Alpha-emitters: pre-clinical and clinical studies
  • Alpha-emitters: radiochemistry
  • Bone-targeted agents for cancer and pain relief
  • Dose-response studies
  • Dosimetry and dose-modeling
  • Intrahepatic sphere therapy
  • Lymphoma radioimmunotherapy
  • Pre-targeting and engineered constructs
  • Radiopeptides
  • Thyroid radionuclide therapy

ISRTRD Workshop

Abstracts

Preliminary Program Schedule

Questions? / Contact Us!